HEALTHCARE TRACKER Faster diagnosis for better treatment: Specific protein estimation made easywith Mispa iSeries

Thomas John,Managing Director,Agappe explains about his company’s Mispa iSeries which provides high quality protein estimation at affordable costs

As the world is moving fast, everyone is looking for faster diagnostic methodologies for faster treatment and better healthcare. The advanced healthcare technologies, new test parameters and methodologies are the need of the hour for the faster diagnosis and treatments.

Agappe with its 28 years of experience in IVD has always been in the forefront to introduce new age products and technologies for the faster and better diagnosis, thus helping the rural and urban population pan India and 75 plus countries.

A decade ago, nearly 35 per cent of specific protein estimations were done by latex method. The latex methods have its own limitations and longer process to generate the reports pose challenges. Due to this limiting factor of latex testing, there was always uncertainty of results especially, in the borderline areas of reference ranges.

The introduction of Mispa iSeries with the combination of Nephelometry & Immunoturbidimetry Technology for the protein estimation replaced the conventional latex method by providing wide measuring range with high sensitivity and better linearity at an affordable cost.

With the motive to provide high quality protein estimation at affordable costs, Agappe sowed the seed of our intelligent breed -Mispa iSeries in 2011. Within a decade, Mispa iSeries emerged as the game changer in the specific protein testing segment in India as well as 75 plus other countries. At present, in India Agappe has more than 15000+ satisfied customers with i-series instruments like Mispa i2 and Misa i3.

First intelligent breed has launched with 6 parameters onboard during 2011. Second generation Mispa i2, a patented Nephelometry equipment, is launched in 2012 which is purely Indian made product with a unique patented technology to provide more accurate and reliable results. It serves 25 parameters with better sensitivity and linearity which ensures flexibility in laboratory testing with marginal investment. The convenient pack size of reagents in 15T and 30 with 35 days open vial stability for Mispa i2 reagents packs make this equipment very much suitable for medium and small labs with lower turnover. Mispa i3 being prefilled individual cartridges has no open vial stability issues, they come in 10s and 30s test packs. disease very fast as well as monitor improvement of the patients. Smart card calibration can be easily estimated without any calibration procedures at an affordable cost. Mispa i3 is an automated prefilled reagent cartridge based Nephelometry analyser which can produce the report within 5 Minutes for the faster diagnosis. Automation with an affordable cost and convenient pack sizes for all special parameters differentiate Mispa i3 with other instruments. The technology used in the equipment has been awarded patent

Mispa iSeries instrument follows smart card calibration technology which avoids reagent wastage and lengthy manual calibration errors. It also saves calibration cost, reagent cost and saves time.

Hence this feature is quite beneficial for parameters like HbA1c, CRP, RF etc. which require multipoint calibration. Factory calibrated smart card for Mispa i-series helps the users a trouble-free operation as well as a peace of mind.

Third generation protein analyser Mispa i3, with prefilled cartridge, was launched in 2017 which serves 23 parameters with better sensitivity and linearity. The assay panel includes cardiovascular risk profile, allergy profile, covid profile, diabetic profile, rheumatology profile, osteoporosis screen profile like Vitamin D etc. Wide test panels with multiple profiles helps the doctors to diagnose the from Indian Patent Office in 2022, in addition to 3 Design Registrations.

Mispa iSeries emerged as the game changer in the specific protein testing and the customers first choice in protein estimation. During these hard times of COVID 19, Mispa iSeries served the mankind with the advanced nephelometry method by providing more than 10 million accurate results of COVID prognostic parameter tests like CRP, D DIMER and FERRITIN.

Let us together serve mankind by providing quality products to ensure accurate and reliable results for the faster diagnosis and treatment.